Pathogenesis of ulcerative colitis

The Lancet

Volumn 342, Issue 8868, 1993, Pages 407-411

  Shanahan, Fergus ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; CROHN DISEASE; GENETIC HETEROGENEITY; HUMAN; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

AUTOIMMUNITY; COLITIS, ULCERATIVE; CROHN DISEASE; HUMAN; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 0027320548     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(93)92818-E     Document Type: Article

References (46)

1. The immunology of inflammatory bowel disease
2. Mechanisms of tissue injury in inflammatory bowel disease
3. The role of the mucosal immune system in inflammatory bowel disease
4. Inflammatory bowel disease
5. Cigarette smoking and its relationship to inflammatory bowel disease: a review
6. Cigarette smoking and intestinal defenses
7. Are the inflammatory bowel diseases autoimmune disorders?
8. The role of autoantibodies and autoimmunity in chronic inflammatory disorders of the gut
9. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis
10. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis
11. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis
12. Ulcerative proctitis in central Sweden 1965-1983: a population-based epidemiologic study
13. Ulcerative colitis: one disease or two? (Quantitative histologic differences between distal and extensive disease)
14. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity
15. IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease
16. Colonic glycoproteins in monozygotic twins with inflammatory bowel disease
17. Relapse of chronic inflammatory bowel disease
18. Neuroendocrine modulation of the immune system Possible implications for inflammatory bowel disease
19. Do life stress events or depression exacerbate inflammatory bowel disease? A prospective study
20. The stress response and the regulation of inflammatory disease
21. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn's disease
22. Neuropeptides and inflammation: the role of substance P
23. 2m: an animal model of HLA-B27-associated human disorders
24. A heritable form of colitis in mice
25. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody
26. Autoantibodies to colonic cells and subcellular fractions in inflammatory bowel disease: do they exist?
27. Mr 40,000 human colonic epithelial protein expression in colonic mucosa and presence of circulating anti-Mr 40,000 antibodies in cotton top tamarins with spontaneous colitis
28. Ulcerative colitis—a disease characterised by the abnormal colonic epithelial cell?
29. Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease
30. Major histocompatibility antigen-restricted cytotoxicity in inflammatory bowel disease
31. Polyclonal nature of the intestinal mucosal lymphocyte populations in inflammatory bowel disease. A molecular genetic evaluation of the immunoglobulin and T-cell antigen receptors
32. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease
33. Immune activation genes in inflammatory bowel disease
34. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification
35. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine
36. Cytokines modulate the growth of normal colonic epithelia
37. A dynamic model for neutrophil localization to inflammatory sites
38. Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease
39. Superantigens: biology, immunology, and potential role in disease
40. Inflammation in ileal reservoirs: 'pouchitis'
41. Imbalance of IL-1 and IL-1 receptor antagonist in the intestinal mucosa of Crohn's disease and ulcerative colitis patients
42. Granulocyte migration in ulcerative colitis
43. Expression of vascular adhesion molecules in inflammatory bowel disease
44. Neutrophil migration across a cultured intestinal epithelium: dependence on a CD 11b/ CD 18 mediated event and enhanced efficiency in physiological direction
45. Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease